A citation-based method for searching scientific literature

Noralane M Lindor, Mary L McMaster, Carl J Lindor, Mark H Greene. J Natl Cancer Inst Monogr 2008
Times Cited: 169







List of co-cited articles
617 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Genetics, genomics, and cancer risk assessment: State of the Art and Future Directions in the Era of Personalized Medicine.
Jeffrey N Weitzel, Kathleen R Blazer, Deborah J MacDonald, Julie O Culver, Kenneth Offit. CA Cancer J Clin 2011
137
10

Hereditary cancer predisposition syndromes.
Judy E Garber, Kenneth Offit. J Clin Oncol 2005
288
9

Beyond Li Fraumeni Syndrome: clinical characteristics of families with p53 germline mutations.
Kelly D Gonzalez, Katie A Noltner, Carolyn H Buzin, Dongqing Gu, Cindy Y Wen-Fong, Vu Q Nguyen, Jennifer H Han, Katrina Lowstuter, Jeffrey Longmate, Steve S Sommer,[...]. J Clin Oncol 2009
305
9

Average risks of breast and ovarian cancer associated with BRCA1 or BRCA2 mutations detected in case Series unselected for family history: a combined analysis of 22 studies.
A Antoniou, P D P Pharoah, S Narod, H A Risch, J E Eyfjord, J L Hopper, N Loman, H Olsson, O Johannsson, A Borg,[...]. Am J Hum Genet 2003
8


Essential elements of genetic cancer risk assessment, counseling, and testing: updated recommendations of the National Society of Genetic Counselors.
Bronson D Riley, Julie O Culver, Cécile Skrzynia, Leigha A Senter, June A Peters, Josephine W Costalas, Faith Callif-Daley, Sherry C Grumet, Katherine S Hunt, Rebecca S Nagy,[...]. J Genet Couns 2012
178
6


A cancer family syndrome in twenty-four kindreds.
F P Li, J F Fraumeni, J J Mulvihill, W A Blattner, M G Dreyfus, M A Tucker, R W Miller. Cancer Res 1988
731
6

Prevalence and type of BRCA mutations in Hispanics undergoing genetic cancer risk assessment in the southwestern United States: a report from the Clinical Cancer Genetics Community Research Network.
Jeffrey N Weitzel, Jessica Clague, Arelis Martir-Negron, Raquel Ogaz, Josef Herzog, Charité Ricker, Chelsy Jungbluth, Cheryl Cina, Paul Duncan, Gary Unzeitig,[...]. J Clin Oncol 2013
92
6

Very high risk of cancer in familial Peutz-Jeghers syndrome.
F M Giardiello, J D Brensinger, A C Tersmette, S N Goodman, G M Petersen, S V Booker, M Cruz-Correa, J A Offerhaus. Gastroenterology 2000
710
6

Inhibition of poly(ADP-ribose) polymerase in tumors from BRCA mutation carriers.
Peter C Fong, David S Boss, Timothy A Yap, Andrew Tutt, Peijun Wu, Marja Mergui-Roelvink, Peter Mortimer, Helen Swaisland, Alan Lau, Mark J O'Connor,[...]. N Engl J Med 2009
6

Meta-analysis of BRCA1 and BRCA2 penetrance.
Sining Chen, Giovanni Parmigiani. J Clin Oncol 2007
980
6

Radiation exposure from CT scans in childhood and subsequent risk of leukaemia and brain tumours: a retrospective cohort study.
Mark S Pearce, Jane A Salotti, Mark P Little, Kieran McHugh, Choonsik Lee, Kwang Pyo Kim, Nicola L Howe, Cecile M Ronckers, Preetha Rajaraman, Alan W Sir Craft,[...]. Lancet 2012
6

A breast cancer prediction model incorporating familial and personal risk factors.
Jonathan Tyrer, Stephen W Duffy, Jack Cuzick. Stat Med 2004
600
5

Ashkenazi Jewish population frequencies for common mutations in BRCA1 and BRCA2.
B B Roa, A A Boyd, K Volcik, C S Richards. Nat Genet 1996
473
5

American Society of Clinical Oncology policy statement update: genetic and genomic testing for cancer susceptibility.
Mark E Robson, Courtney D Storm, Jeffrey Weitzel, Dana S Wollins, Kenneth Offit. J Clin Oncol 2010
274
5


Association of risk-reducing surgery in BRCA1 or BRCA2 mutation carriers with cancer risk and mortality.
Susan M Domchek, Tara M Friebel, Christian F Singer, D Gareth Evans, Henry T Lynch, Claudine Isaacs, Judy E Garber, Susan L Neuhausen, Ellen Matloff, Rosalind Eeles,[...]. JAMA 2010
771
5

High cancer risk in Peutz-Jeghers syndrome: a systematic review and surveillance recommendations.
M G F van Lier, A Wagner, E M H Mathus-Vliegen, E J Kuipers, E W Steyerberg, M E van Leerdam. Am J Gastroenterol 2010
240
5

Genetic cancer risk assessment and counseling: recommendations of the national society of genetic counselors.
Angela Trepanier, Mary Ahrens, Wendy McKinnon, June Peters, Jill Stopfer, Sherry Campbell Grumet, Susan Manley, Julie O Culver, Ronald Acton, Joy Larsen-Haidle,[...]. J Genet Couns 2004
143
5

Adverse events in cancer genetic testing: medical, ethical, legal, and financial implications.
Karina L Brierley, Erica Blouch, Whitney Cogswell, Jeanne P Homer, Debbie Pencarinha, Christine L Stanislaw, Ellen T Matloff. Cancer J 2012
62
8

P53 germline mutations in childhood cancers and cancer risk for carrier individuals.
A Chompret, L Brugières, M Ronsin, M Gardes, F Dessarps-Freichey, A Abel, D Hua, L Ligot, M G Dondon, B Bressac-de Paillerets,[...]. Br J Cancer 2000
225
5

Genetic predisposition syndromes and their management.
David M Euhus, Linda Robinson. Surg Clin North Am 2013
14
35

Relative frequency and morphology of cancers in carriers of germline TP53 mutations.
J M Birch, R D Alston, R J McNally, D G Evans, A M Kelsey, M Harris, O B Eden, J M Varley. Oncogene 2001
264
5

TP53 germline mutation testing in 180 families suspected of Li-Fraumeni syndrome: mutation detection rate and relative frequency of cancers in different familial phenotypes.
Marielle W G Ruijs, Senno Verhoef, Matti A Rookus, Roelof Pruntel, Annemarie H van der Hout, Frans B L Hogervorst, I Kluijt, Rolf H Sijmons, Cora M Aalfs, Anja Wagner,[...]. J Med Genet 2010
159
5

Lifetime cancer risks in individuals with germline PTEN mutations.
Min-Han Tan, Jessica L Mester, Joanne Ngeow, Lisa A Rybicki, Mohammed S Orloff, Charis Eng. Clin Cancer Res 2012
388
5

Li-Fraumeni and related syndromes: correlation between tumor type, family structure, and TP53 genotype.
Magali Olivier, David E Goldgar, Nayanta Sodha, Hiroko Ohgaki, Paul Kleihues, Pierre Hainaut, Rosalind A Eeles. Cancer Res 2003
265
5

Risk of cancer incidence before the age of 15 years after exposure to ionising radiation from computed tomography: results from a German cohort study.
L Krille, S Dreger, R Schindel, T Albrecht, M Asmussen, J Barkhausen, J D Berthold, A Chavan, C Claussen, M Forsting,[...]. Radiat Environ Biophys 2015
82
6

Are the studies on cancer risk from CT scans biased by indication? Elements of answer from a large-scale cohort study in France.
N Journy, J-L Rehel, H Ducou Le Pointe, C Lee, H Brisse, J-F Chateil, S Caer-Lorho, D Laurier, M-O Bernier. Br J Cancer 2015
111
5

Peutz-Jeghers syndrome: a systematic review and recommendations for management.
A D Beggs, A R Latchford, H F A Vasen, G Moslein, A Alonso, S Aretz, L Bertario, I Blanco, S Bülow, J Burn,[...]. Gut 2010
315
5

American Cancer Society guidelines for breast screening with MRI as an adjunct to mammography.
Debbie Saslow, Carla Boetes, Wylie Burke, Steven Harms, Martin O Leach, Constance D Lehman, Elizabeth Morris, Etta Pisano, Mitchell Schnall, Stephen Sener,[...]. CA Cancer J Clin 2007
4

Projecting individualized probabilities of developing breast cancer for white females who are being examined annually.
M H Gail, L A Brinton, D P Byar, D K Corle, S B Green, C Schairer, J J Mulvihill. J Natl Cancer Inst 1989
4


Germline mutations of the p53 tumor-suppressor gene in children and young adults with second malignant neoplasms.
D Malkin, K W Jolly, N Barbier, A T Look, S H Friend, M C Gebhardt, T I Andersen, A L Børresen, F P Li, J Garber. N Engl J Med 1992
237
4


Germline p53 mutations in a cohort with childhood sarcoma: sex differences in cancer risk.
Shih-Jen Hwang, Guillermina Lozano, Christopher I Amos, Louise C Strong. Am J Hum Genet 2003
134
4

Germ line p53 mutations in a familial syndrome of breast cancer, sarcomas, and other neoplasms.
D Malkin, F P Li, L C Strong, J F Fraumeni, C E Nelson, D H Kim, J Kassel, M A Gryka, F Z Bischoff, M A Tainsky. Science 1990
4

Detailed haplotype analysis at the TP53 locus in p.R337H mutation carriers in the population of Southern Brazil: evidence for a founder effect.
Sonia Garritano, Federica Gemignani, Edenir Inez Palmero, Magali Olivier, Ghyslaine Martel-Planche, Florence Le Calvez-Kelm, Laurence Brugiéres, Fernando Regla Vargas, Ricardo Renzo Brentani, Patricia Ashton-Prolla,[...]. Hum Mutat 2010
79
5

Biochemical and imaging surveillance in germline TP53 mutation carriers with Li-Fraumeni syndrome: a prospective observational study.
Anita Villani, Uri Tabori, Joshua Schiffman, Adam Shlien, Joseph Beyene, Harriet Druker, Ana Novokmet, Jonathan Finlay, David Malkin. Lancet Oncol 2011
227
4

Meta-analysis identifies four new loci associated with testicular germ cell tumor.
Charles C Chung, Peter A Kanetsky, Zhaoming Wang, Michelle A T Hildebrandt, Roelof Koster, Rolf I Skotheim, Christian P Kratz, Clare Turnbull, Victoria K Cortessis, Anne C Bakken,[...]. Nat Genet 2013
116
4

The Y deletion gr/gr and susceptibility to testicular germ cell tumor.
Katherine L Nathanson, Peter A Kanetsky, Rachel Hawes, David J Vaughn, Richard Letrero, Kathy Tucker, Michael Friedlander, Kelly-Anne Phillips, David Hogg, Michael A S Jewett,[...]. Am J Hum Genet 2005
128
4

Cancer risks associated with germline mutations in MLH1, MSH2, and MSH6 genes in Lynch syndrome.
Valérie Bonadona, Bernard Bonaïti, Sylviane Olschwang, Sophie Grandjouan, Laetitia Huiart, Michel Longy, Rosine Guimbaud, Bruno Buecher, Yves-Jean Bignon, Olivier Caron,[...]. JAMA 2011
532
4

Molecular basis of the Li-Fraumeni syndrome: an update from the French LFS families.
G Bougeard, R Sesboüé, S Baert-Desurmont, S Vasseur, C Martin, J Tinat, L Brugières, A Chompret, B Bressac de Paillerets, D Stoppa-Lyonnet,[...]. J Med Genet 2008
136
4

Bilateral prophylactic mastectomy reduces breast cancer risk in BRCA1 and BRCA2 mutation carriers: the PROSE Study Group.
Timothy R Rebbeck, Tara Friebel, Henry T Lynch, Susan L Neuhausen, Laura van 't Veer, Judy E Garber, Gareth R Evans, Steven A Narod, Claudine Isaacs, Ellen Matloff,[...]. J Clin Oncol 2004
647
4


Cancer risks and mortality in heterozygous ATM mutation carriers.
Deborah Thompson, Silvia Duedal, Jennifer Kirner, Lesley McGuffog, James Last, Anne Reiman, Philip Byrd, Malcolm Taylor, Douglas F Easton. J Natl Cancer Inst 2005
297
4

Breast and ovarian cancer risks due to inherited mutations in BRCA1 and BRCA2.
Mary-Claire King, Joan H Marks, Jessica B Mandell. Science 2003
4

Global cancer statistics.
Ahmedin Jemal, Freddie Bray, Melissa M Center, Jacques Ferlay, Elizabeth Ward, David Forman. CA Cancer J Clin 2011
4

von Hippel-Lindau disease: a clinical and scientific review.
Eamonn R Maher, Hartmut Ph Neumann, Stéphane Richard. Eur J Hum Genet 2011
276
4

Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology.
Sue Richards, Nazneen Aziz, Sherri Bale, David Bick, Soma Das, Julie Gastier-Foster, Wayne W Grody, Madhuri Hegde, Elaine Lyon, Elaine Spector,[...]. Genet Med 2015
4


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.